nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfamethoxazole—CYP3A4—type 2 diabetes mellitus	0.0764	0.534	CbGaD
Sulfamethoxazole—ALB—type 2 diabetes mellitus	0.0666	0.466	CbGaD
Sulfamethoxazole—Glisoxepide—Tolazamide—type 2 diabetes mellitus	0.0455	0.126	CrCrCtD
Sulfamethoxazole—Glisoxepide—Glimepiride—type 2 diabetes mellitus	0.0455	0.126	CrCrCtD
Sulfamethoxazole—Glisoxepide—Tolbutamide—type 2 diabetes mellitus	0.0431	0.12	CrCrCtD
Sulfamethoxazole—Glisoxepide—Glipizide—type 2 diabetes mellitus	0.0431	0.12	CrCrCtD
Sulfamethoxazole—Glisoxepide—Gliclazide—type 2 diabetes mellitus	0.0431	0.12	CrCrCtD
Sulfamethoxazole—Glisoxepide—Chlorpropamide—type 2 diabetes mellitus	0.0394	0.109	CrCrCtD
Sulfamethoxazole—Glisoxepide—Glyburide—type 2 diabetes mellitus	0.0299	0.0828	CrCrCtD
Sulfamethoxazole—UGT1A9—Nateglinide—type 2 diabetes mellitus	0.0292	0.0866	CbGbCtD
Sulfamethoxazole—Sulfacetamide—Tolazamide—type 2 diabetes mellitus	0.0189	0.0524	CrCrCtD
Sulfamethoxazole—Sulfacetamide—Tolbutamide—type 2 diabetes mellitus	0.0179	0.0496	CrCrCtD
Sulfamethoxazole—Sulfacetamide—Gliclazide—type 2 diabetes mellitus	0.0179	0.0496	CrCrCtD
Sulfamethoxazole—Sulfacetamide—Chlorpropamide—type 2 diabetes mellitus	0.0164	0.0454	CrCrCtD
Sulfamethoxazole—PTGS1—Pioglitazone—type 2 diabetes mellitus	0.016	0.0475	CbGbCtD
Sulfamethoxazole—PTGS1—Chlorpropamide—type 2 diabetes mellitus	0.016	0.0475	CbGbCtD
Sulfamethoxazole—PTGS1—Rosiglitazone—type 2 diabetes mellitus	0.0148	0.0438	CbGbCtD
Sulfamethoxazole—ALB—Gliclazide—type 2 diabetes mellitus	0.0141	0.0417	CbGbCtD
Sulfamethoxazole—ALB—Repaglinide—type 2 diabetes mellitus	0.0132	0.0392	CbGbCtD
Sulfamethoxazole—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.0128	0.0379	CbGbCtD
Sulfamethoxazole—PTGS1—Nateglinide—type 2 diabetes mellitus	0.0121	0.036	CbGbCtD
Sulfamethoxazole—PTGS1—Irbesartan—type 2 diabetes mellitus	0.0116	0.0345	CbGbCtD
Sulfamethoxazole—ALB—Rosiglitazone—type 2 diabetes mellitus	0.011	0.0327	CbGbCtD
Sulfamethoxazole—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.0102	0.0303	CbGbCtD
Sulfamethoxazole—ALB—Valsartan—type 2 diabetes mellitus	0.00974	0.0289	CbGbCtD
Sulfamethoxazole—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.00923	0.0274	CbGbCtD
Sulfamethoxazole—ALB—Nateglinide—type 2 diabetes mellitus	0.00905	0.0269	CbGbCtD
Sulfamethoxazole—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.00891	0.0264	CbGbCtD
Sulfamethoxazole—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.00852	0.0253	CbGbCtD
Sulfamethoxazole—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.00823	0.0244	CbGbCtD
Sulfamethoxazole—CYP2C9—Glipizide—type 2 diabetes mellitus	0.00815	0.0242	CbGbCtD
Sulfamethoxazole—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.00757	0.0225	CbGbCtD
Sulfamethoxazole—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.00671	0.0199	CbGbCtD
Sulfamethoxazole—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.00644	0.0191	CbGbCtD
Sulfamethoxazole—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.00644	0.0191	CbGbCtD
Sulfamethoxazole—ALB—Glyburide—type 2 diabetes mellitus	0.00612	0.0181	CbGbCtD
Sulfamethoxazole—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.00594	0.0176	CbGbCtD
Sulfamethoxazole—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00581	0.0172	CbGbCtD
Sulfamethoxazole—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.00574	0.017	CbGbCtD
Sulfamethoxazole—ALB—Losartan—type 2 diabetes mellitus	0.00559	0.0166	CbGbCtD
Sulfamethoxazole—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00525	0.0156	CbGbCtD
Sulfamethoxazole—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00518	0.0154	CbGbCtD
Sulfamethoxazole—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00488	0.0145	CbGbCtD
Sulfamethoxazole—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00474	0.0141	CbGbCtD
Sulfamethoxazole—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00468	0.0139	CbGbCtD
Sulfamethoxazole—CYP2C8—Losartan—type 2 diabetes mellitus	0.00432	0.0128	CbGbCtD
Sulfamethoxazole—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00414	0.0123	CbGbCtD
Sulfamethoxazole—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00374	0.0111	CbGbCtD
Sulfamethoxazole—CYP2C9—Glyburide—type 2 diabetes mellitus	0.0033	0.00978	CbGbCtD
Sulfamethoxazole—CYP2C9—Losartan—type 2 diabetes mellitus	0.00301	0.00895	CbGbCtD
Sulfamethoxazole—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00284	0.00842	CbGbCtD
Sulfamethoxazole—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00272	0.00807	CbGbCtD
Sulfamethoxazole—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00272	0.00807	CbGbCtD
Sulfamethoxazole—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00257	0.00763	CbGbCtD
Sulfamethoxazole—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00192	0.00569	CbGbCtD
Sulfamethoxazole—CYP3A4—Losartan—type 2 diabetes mellitus	0.00175	0.0052	CbGbCtD
Sulfamethoxazole—NAT1—islet of Langerhans—type 2 diabetes mellitus	0.00155	0.126	CbGeAlD
Sulfamethoxazole—NAT1—retina—type 2 diabetes mellitus	0.00133	0.108	CbGeAlD
Sulfamethoxazole—NAT1—nephron tubule—type 2 diabetes mellitus	0.00125	0.101	CbGeAlD
Sulfamethoxazole—NAT1—pancreas—type 2 diabetes mellitus	0.00109	0.0886	CbGeAlD
Sulfamethoxazole—NAT1—cortex of kidney—type 2 diabetes mellitus	0.00107	0.0869	CbGeAlD
Sulfamethoxazole—NAT1—adipose tissue—type 2 diabetes mellitus	0.000991	0.0804	CbGeAlD
Sulfamethoxazole—NAT2—liver—type 2 diabetes mellitus	0.000764	0.062	CbGeAlD
Sulfamethoxazole—NAT1—liver—type 2 diabetes mellitus	0.000695	0.0564	CbGeAlD
Sulfamethoxazole—UGT1A9—kidney—type 2 diabetes mellitus	0.000653	0.0529	CbGeAlD
Sulfamethoxazole—Glisoxepide—ABCC8—type 2 diabetes mellitus	0.000539	0.266	CrCbGaD
Sulfamethoxazole—PTGS1—artery—type 2 diabetes mellitus	0.000505	0.0409	CbGeAlD
Sulfamethoxazole—Sulfisoxazole—EDNRA—type 2 diabetes mellitus	0.000457	0.225	CrCbGaD
Sulfamethoxazole—PTGS1—endothelium—type 2 diabetes mellitus	0.000426	0.0346	CbGeAlD
Sulfamethoxazole—UGT1A9—liver—type 2 diabetes mellitus	0.000413	0.0335	CbGeAlD
Sulfamethoxazole—Glisoxepide—KCNJ11—type 2 diabetes mellitus	0.000379	0.187	CrCbGaD
Sulfamethoxazole—CYP2C8—kidney—type 2 diabetes mellitus	0.000212	0.0172	CbGeAlD
Sulfamethoxazole—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.000192	0.0156	CbGeAlD
Sulfamethoxazole—ALB—liver—type 2 diabetes mellitus	0.00019	0.0154	CbGeAlD
Sulfamethoxazole—PTGS1—cardiovascular system—type 2 diabetes mellitus	0.000175	0.0142	CbGeAlD
Sulfamethoxazole—PTGS1—kidney—type 2 diabetes mellitus	0.000172	0.0139	CbGeAlD
Sulfamethoxazole—PTGS1—adipose tissue—type 2 diabetes mellitus	0.000155	0.0125	CbGeAlD
Sulfamethoxazole—CYP3A4—kidney—type 2 diabetes mellitus	0.000143	0.0116	CbGeAlD
Sulfamethoxazole—CYP2C8—liver—type 2 diabetes mellitus	0.000134	0.0109	CbGeAlD
Sulfamethoxazole—CYP2C9—liver—type 2 diabetes mellitus	0.000119	0.00964	CbGeAlD
Sulfamethoxazole—Sulfamethazine—ALB—type 2 diabetes mellitus	9.52e-05	0.047	CrCbGaD
Sulfamethoxazole—Sulfadiazine—CYP2E1—type 2 diabetes mellitus	9.52e-05	0.047	CrCbGaD
Sulfamethoxazole—Sulfamerazine—ALB—type 2 diabetes mellitus	9.3e-05	0.0459	CrCbGaD
Sulfamethoxazole—CYP3A4—liver—type 2 diabetes mellitus	9.06e-05	0.00735	CbGeAlD
Sulfamethoxazole—Sulfamethizole—ALB—type 2 diabetes mellitus	7.21e-05	0.0356	CrCbGaD
Sulfamethoxazole—Pruritus—Glimepiride—type 2 diabetes mellitus	6.51e-05	0.000672	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	6.49e-05	0.000669	CcSEcCtD
Sulfamethoxazole—Tension—Irbesartan—type 2 diabetes mellitus	6.47e-05	0.000667	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	6.47e-05	0.000667	CcSEcCtD
Sulfamethoxazole—Sulfanilamide—CYP2E1—type 2 diabetes mellitus	6.46e-05	0.0319	CrCbGaD
Sulfamethoxazole—Myalgia—Orlistat—type 2 diabetes mellitus	6.46e-05	0.000666	CcSEcCtD
Sulfamethoxazole—Hepatobiliary disease—Ramipril—type 2 diabetes mellitus	6.44e-05	0.000664	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	6.41e-05	0.000661	CcSEcCtD
Sulfamethoxazole—Nervousness—Irbesartan—type 2 diabetes mellitus	6.41e-05	0.00066	CcSEcCtD
Sulfamethoxazole—Agranulocytosis—Ramipril—type 2 diabetes mellitus	6.36e-05	0.000655	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Glimepiride—type 2 diabetes mellitus	6.3e-05	0.000649	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	6.28e-05	0.000647	CcSEcCtD
Sulfamethoxazole—Vomiting—Glipizide—type 2 diabetes mellitus	6.27e-05	0.000647	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	6.26e-05	0.000646	CcSEcCtD
Sulfamethoxazole—Dizziness—Pioglitazone—type 2 diabetes mellitus	6.25e-05	0.000644	CcSEcCtD
Sulfamethoxazole—Rash—Glipizide—type 2 diabetes mellitus	6.22e-05	0.000641	CcSEcCtD
Sulfamethoxazole—Dermatitis—Glipizide—type 2 diabetes mellitus	6.21e-05	0.000641	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	6.21e-05	0.00064	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	6.21e-05	0.00064	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	6.19e-05	0.000638	CcSEcCtD
Sulfamethoxazole—Headache—Glipizide—type 2 diabetes mellitus	6.18e-05	0.000637	CcSEcCtD
Sulfamethoxazole—Insomnia—Gliclazide—type 2 diabetes mellitus	6.17e-05	0.000636	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Valsartan—type 2 diabetes mellitus	6.14e-05	0.000633	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	6.13e-05	0.000632	CcSEcCtD
Sulfamethoxazole—Hepatitis—Ramipril—type 2 diabetes mellitus	6.11e-05	0.00063	CcSEcCtD
Sulfamethoxazole—Tension—Losartan—type 2 diabetes mellitus	6.09e-05	0.000628	CcSEcCtD
Sulfamethoxazole—Dizziness—Glimepiride—type 2 diabetes mellitus	6.09e-05	0.000628	CcSEcCtD
Sulfamethoxazole—Skin disorder—Valsartan—type 2 diabetes mellitus	6.08e-05	0.000627	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Gliclazide—type 2 diabetes mellitus	6.08e-05	0.000627	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Orlistat—type 2 diabetes mellitus	6.07e-05	0.000626	CcSEcCtD
Sulfamethoxazole—Dizziness—Sitagliptin—type 2 diabetes mellitus	6.07e-05	0.000626	CcSEcCtD
Sulfamethoxazole—Urticaria—Glyburide—type 2 diabetes mellitus	6.03e-05	0.000622	CcSEcCtD
Sulfamethoxazole—Nervousness—Losartan—type 2 diabetes mellitus	6.03e-05	0.000622	CcSEcCtD
Sulfamethoxazole—Angioedema—Irbesartan—type 2 diabetes mellitus	6.03e-05	0.000621	CcSEcCtD
Sulfamethoxazole—Skin disorder—Orlistat—type 2 diabetes mellitus	6.01e-05	0.00062	CcSEcCtD
Sulfamethoxazole—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	6.01e-05	0.000619	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Glyburide—type 2 diabetes mellitus	6e-05	0.000619	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Gliclazide—type 2 diabetes mellitus	6e-05	0.000619	CcSEcCtD
Sulfamethoxazole—Sulfadiazine—CYP3A4—type 2 diabetes mellitus	5.99e-05	0.0296	CrCbGaD
Sulfamethoxazole—Anorexia—Valsartan—type 2 diabetes mellitus	5.97e-05	0.000616	CcSEcCtD
Sulfamethoxazole—Asthenia—Bromocriptine—type 2 diabetes mellitus	5.96e-05	0.000614	CcSEcCtD
Sulfamethoxazole—Myalgia—Metformin—type 2 diabetes mellitus	5.95e-05	0.000613	CcSEcCtD
Sulfamethoxazole—Vertigo—Irbesartan—type 2 diabetes mellitus	5.93e-05	0.000611	CcSEcCtD
Sulfamethoxazole—Headache—Pioglitazone—type 2 diabetes mellitus	5.92e-05	0.00061	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	5.91e-05	0.000609	CcSEcCtD
Sulfamethoxazole—Leukopenia—Irbesartan—type 2 diabetes mellitus	5.9e-05	0.000609	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	5.89e-05	0.000607	CcSEcCtD
Sulfamethoxazole—Fatigue—Gliclazide—type 2 diabetes mellitus	5.88e-05	0.000606	CcSEcCtD
Sulfamethoxazole—Nausea—Glipizide—type 2 diabetes mellitus	5.86e-05	0.000604	CcSEcCtD
Sulfamethoxazole—Vomiting—Glimepiride—type 2 diabetes mellitus	5.85e-05	0.000604	CcSEcCtD
Sulfamethoxazole—Vomiting—Sitagliptin—type 2 diabetes mellitus	5.83e-05	0.000602	CcSEcCtD
Sulfamethoxazole—Rash—Glimepiride—type 2 diabetes mellitus	5.8e-05	0.000598	CcSEcCtD
Sulfamethoxazole—Dermatitis—Glimepiride—type 2 diabetes mellitus	5.8e-05	0.000598	CcSEcCtD
Sulfamethoxazole—Rash—Sitagliptin—type 2 diabetes mellitus	5.79e-05	0.000597	CcSEcCtD
Sulfamethoxazole—Dermatitis—Sitagliptin—type 2 diabetes mellitus	5.78e-05	0.000596	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Ramipril—type 2 diabetes mellitus	5.78e-05	0.000596	CcSEcCtD
Sulfamethoxazole—Headache—Glimepiride—type 2 diabetes mellitus	5.77e-05	0.000595	CcSEcCtD
Sulfamethoxazole—Dapsone—CYP2E1—type 2 diabetes mellitus	5.77e-05	0.0285	CrCbGaD
Sulfamethoxazole—Cough—Irbesartan—type 2 diabetes mellitus	5.75e-05	0.000593	CcSEcCtD
Sulfamethoxazole—Headache—Sitagliptin—type 2 diabetes mellitus	5.75e-05	0.000593	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	5.71e-05	0.000588	CcSEcCtD
Sulfamethoxazole—Tinnitus—Ramipril—type 2 diabetes mellitus	5.7e-05	0.000588	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	5.68e-05	0.000586	CcSEcCtD
Sulfamethoxazole—Angioedema—Losartan—type 2 diabetes mellitus	5.67e-05	0.000585	CcSEcCtD
Sulfamethoxazole—Insomnia—Valsartan—type 2 diabetes mellitus	5.66e-05	0.000584	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	5.64e-05	0.000581	CcSEcCtD
Sulfamethoxazole—Arthralgia—Irbesartan—type 2 diabetes mellitus	5.61e-05	0.000579	CcSEcCtD
Sulfamethoxazole—Myalgia—Irbesartan—type 2 diabetes mellitus	5.61e-05	0.000579	CcSEcCtD
Sulfamethoxazole—Insomnia—Orlistat—type 2 diabetes mellitus	5.6e-05	0.000577	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Glyburide—type 2 diabetes mellitus	5.59e-05	0.000577	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Metformin—type 2 diabetes mellitus	5.59e-05	0.000577	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Metformin—type 2 diabetes mellitus	5.58e-05	0.000576	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Valsartan—type 2 diabetes mellitus	5.58e-05	0.000576	CcSEcCtD
Sulfamethoxazole—Vertigo—Losartan—type 2 diabetes mellitus	5.58e-05	0.000575	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	5.58e-05	0.000575	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	5.57e-05	0.000575	CcSEcCtD
Sulfamethoxazole—Leukopenia—Losartan—type 2 diabetes mellitus	5.56e-05	0.000573	CcSEcCtD
Sulfamethoxazole—Skin disorder—Metformin—type 2 diabetes mellitus	5.54e-05	0.000571	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Ramipril—type 2 diabetes mellitus	5.52e-05	0.000569	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Valsartan—type 2 diabetes mellitus	5.51e-05	0.000568	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	5.51e-05	0.000568	CcSEcCtD
Sulfamethoxazole—Dizziness—Bromocriptine—type 2 diabetes mellitus	5.49e-05	0.000566	CcSEcCtD
Sulfamethoxazole—Nausea—Glimepiride—type 2 diabetes mellitus	5.47e-05	0.000564	CcSEcCtD
Sulfamethoxazole—Nausea—Sitagliptin—type 2 diabetes mellitus	5.45e-05	0.000562	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Orlistat—type 2 diabetes mellitus	5.45e-05	0.000562	CcSEcCtD
Sulfamethoxazole—Asthenia—Glyburide—type 2 diabetes mellitus	5.45e-05	0.000562	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Valsartan—type 2 diabetes mellitus	5.44e-05	0.000561	CcSEcCtD
Sulfamethoxazole—Anorexia—Metformin—type 2 diabetes mellitus	5.44e-05	0.000561	CcSEcCtD
Sulfamethoxazole—Cough—Losartan—type 2 diabetes mellitus	5.42e-05	0.000558	CcSEcCtD
Sulfamethoxazole—Urticaria—Gliclazide—type 2 diabetes mellitus	5.42e-05	0.000558	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	5.41e-05	0.000558	CcSEcCtD
Sulfamethoxazole—Fatigue—Valsartan—type 2 diabetes mellitus	5.4e-05	0.000557	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Gliclazide—type 2 diabetes mellitus	5.39e-05	0.000556	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Gliclazide—type 2 diabetes mellitus	5.39e-05	0.000556	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	5.38e-05	0.000555	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Orlistat—type 2 diabetes mellitus	5.38e-05	0.000555	CcSEcCtD
Sulfamethoxazole—Pruritus—Glyburide—type 2 diabetes mellitus	5.37e-05	0.000554	CcSEcCtD
Sulfamethoxazole—Mental disorder—Ramipril—type 2 diabetes mellitus	5.36e-05	0.000552	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	5.34e-05	0.000551	CcSEcCtD
Sulfamethoxazole—Fatigue—Orlistat—type 2 diabetes mellitus	5.34e-05	0.00055	CcSEcCtD
Sulfamethoxazole—Malnutrition—Ramipril—type 2 diabetes mellitus	5.32e-05	0.000549	CcSEcCtD
Sulfamethoxazole—Arthralgia—Losartan—type 2 diabetes mellitus	5.28e-05	0.000545	CcSEcCtD
Sulfamethoxazole—Myalgia—Losartan—type 2 diabetes mellitus	5.28e-05	0.000545	CcSEcCtD
Sulfamethoxazole—Vomiting—Bromocriptine—type 2 diabetes mellitus	5.28e-05	0.000544	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	5.28e-05	0.000544	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	5.27e-05	0.000543	CcSEcCtD
Sulfamethoxazole—Rash—Bromocriptine—type 2 diabetes mellitus	5.24e-05	0.00054	CcSEcCtD
Sulfamethoxazole—Dermatitis—Bromocriptine—type 2 diabetes mellitus	5.23e-05	0.000539	CcSEcCtD
Sulfamethoxazole—Skin disorder—Irbesartan—type 2 diabetes mellitus	5.23e-05	0.000539	CcSEcCtD
Sulfamethoxazole—Tension—Ramipril—type 2 diabetes mellitus	5.22e-05	0.000538	CcSEcCtD
Sulfamethoxazole—Headache—Bromocriptine—type 2 diabetes mellitus	5.2e-05	0.000536	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	5.2e-05	0.000536	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Glyburide—type 2 diabetes mellitus	5.19e-05	0.000536	CcSEcCtD
Sulfamethoxazole—Nervousness—Ramipril—type 2 diabetes mellitus	5.17e-05	0.000533	CcSEcCtD
Sulfamethoxazole—Anorexia—Irbesartan—type 2 diabetes mellitus	5.13e-05	0.000529	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	5.12e-05	0.000528	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Metformin—type 2 diabetes mellitus	5.08e-05	0.000524	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Losartan—type 2 diabetes mellitus	5.07e-05	0.000522	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	5.06e-05	0.000522	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	5.02e-05	0.000518	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Metformin—type 2 diabetes mellitus	5.02e-05	0.000518	CcSEcCtD
Sulfamethoxazole—Urticaria—Valsartan—type 2 diabetes mellitus	4.98e-05	0.000513	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Losartan—type 2 diabetes mellitus	4.97e-05	0.000512	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Losartan—type 2 diabetes mellitus	4.96e-05	0.000511	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Metformin—type 2 diabetes mellitus	4.96e-05	0.000511	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Valsartan—type 2 diabetes mellitus	4.95e-05	0.000511	CcSEcCtD
Sulfamethoxazole—Nausea—Bromocriptine—type 2 diabetes mellitus	4.93e-05	0.000509	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	4.92e-05	0.000508	CcSEcCtD
Sulfamethoxazole—Fatigue—Metformin—type 2 diabetes mellitus	4.92e-05	0.000507	CcSEcCtD
Sulfamethoxazole—Urticaria—Orlistat—type 2 diabetes mellitus	4.92e-05	0.000507	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	4.9e-05	0.000506	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Orlistat—type 2 diabetes mellitus	4.89e-05	0.000504	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Orlistat—type 2 diabetes mellitus	4.89e-05	0.000504	CcSEcCtD
Sulfamethoxazole—Asthenia—Gliclazide—type 2 diabetes mellitus	4.89e-05	0.000504	CcSEcCtD
Sulfamethoxazole—Angioedema—Ramipril—type 2 diabetes mellitus	4.86e-05	0.000501	CcSEcCtD
Sulfamethoxazole—Anorexia—Losartan—type 2 diabetes mellitus	4.83e-05	0.000498	CcSEcCtD
Sulfamethoxazole—Vomiting—Glyburide—type 2 diabetes mellitus	4.83e-05	0.000498	CcSEcCtD
Sulfamethoxazole—Pruritus—Gliclazide—type 2 diabetes mellitus	4.82e-05	0.000497	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Irbesartan—type 2 diabetes mellitus	4.8e-05	0.000495	CcSEcCtD
Sulfamethoxazole—Rash—Glyburide—type 2 diabetes mellitus	4.79e-05	0.000494	CcSEcCtD
Sulfamethoxazole—Dermatitis—Glyburide—type 2 diabetes mellitus	4.78e-05	0.000493	CcSEcCtD
Sulfamethoxazole—Vertigo—Ramipril—type 2 diabetes mellitus	4.78e-05	0.000493	CcSEcCtD
Sulfamethoxazole—Leukopenia—Ramipril—type 2 diabetes mellitus	4.76e-05	0.000491	CcSEcCtD
Sulfamethoxazole—Headache—Glyburide—type 2 diabetes mellitus	4.76e-05	0.00049	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Irbesartan—type 2 diabetes mellitus	4.74e-05	0.000489	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Irbesartan—type 2 diabetes mellitus	4.68e-05	0.000482	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Gliclazide—type 2 diabetes mellitus	4.66e-05	0.000481	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	4.66e-05	0.000481	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	4.65e-05	0.000479	CcSEcCtD
Sulfamethoxazole—Cough—Ramipril—type 2 diabetes mellitus	4.64e-05	0.000479	CcSEcCtD
Sulfamethoxazole—Fatigue—Irbesartan—type 2 diabetes mellitus	4.64e-05	0.000478	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	4.61e-05	0.000476	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Valsartan—type 2 diabetes mellitus	4.61e-05	0.000476	CcSEcCtD
Sulfamethoxazole—Convulsion—Ramipril—type 2 diabetes mellitus	4.61e-05	0.000475	CcSEcCtD
Sulfamethoxazole—Insomnia—Losartan—type 2 diabetes mellitus	4.58e-05	0.000472	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Orlistat—type 2 diabetes mellitus	4.56e-05	0.00047	CcSEcCtD
Sulfamethoxazole—Urticaria—Metformin—type 2 diabetes mellitus	4.53e-05	0.000467	CcSEcCtD
Sulfamethoxazole—Myalgia—Ramipril—type 2 diabetes mellitus	4.53e-05	0.000467	CcSEcCtD
Sulfamethoxazole—Arthralgia—Ramipril—type 2 diabetes mellitus	4.53e-05	0.000467	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Losartan—type 2 diabetes mellitus	4.52e-05	0.000466	CcSEcCtD
Sulfamethoxazole—Nausea—Glyburide—type 2 diabetes mellitus	4.51e-05	0.000465	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Metformin—type 2 diabetes mellitus	4.51e-05	0.000465	CcSEcCtD
Sulfamethoxazole—Dizziness—Gliclazide—type 2 diabetes mellitus	4.51e-05	0.000465	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	4.5e-05	0.000464	CcSEcCtD
Sulfamethoxazole—Asthenia—Valsartan—type 2 diabetes mellitus	4.49e-05	0.000463	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Losartan—type 2 diabetes mellitus	4.46e-05	0.00046	CcSEcCtD
Sulfamethoxazole—Asthenia—Orlistat—type 2 diabetes mellitus	4.44e-05	0.000458	CcSEcCtD
Sulfamethoxazole—Pruritus—Valsartan—type 2 diabetes mellitus	4.43e-05	0.000457	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Losartan—type 2 diabetes mellitus	4.4e-05	0.000454	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	4.4e-05	0.000454	CcSEcCtD
Sulfamethoxazole—Pruritus—Orlistat—type 2 diabetes mellitus	4.38e-05	0.000451	CcSEcCtD
Sulfamethoxazole—Fatigue—Losartan—type 2 diabetes mellitus	4.37e-05	0.00045	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	4.34e-05	0.000448	CcSEcCtD
Sulfamethoxazole—Vomiting—Gliclazide—type 2 diabetes mellitus	4.33e-05	0.000447	CcSEcCtD
Sulfamethoxazole—Rash—Gliclazide—type 2 diabetes mellitus	4.3e-05	0.000443	CcSEcCtD
Sulfamethoxazole—Dermatitis—Gliclazide—type 2 diabetes mellitus	4.29e-05	0.000443	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Valsartan—type 2 diabetes mellitus	4.29e-05	0.000442	CcSEcCtD
Sulfamethoxazole—Urticaria—Irbesartan—type 2 diabetes mellitus	4.28e-05	0.000441	CcSEcCtD
Sulfamethoxazole—Headache—Gliclazide—type 2 diabetes mellitus	4.27e-05	0.00044	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Ramipril—type 2 diabetes mellitus	4.26e-05	0.000439	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Irbesartan—type 2 diabetes mellitus	4.25e-05	0.000439	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Irbesartan—type 2 diabetes mellitus	4.25e-05	0.000439	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	4.25e-05	0.000438	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Orlistat—type 2 diabetes mellitus	4.23e-05	0.000437	CcSEcCtD
Sulfamethoxazole—Skin disorder—Ramipril—type 2 diabetes mellitus	4.22e-05	0.000435	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	4.14e-05	0.000427	CcSEcCtD
Sulfamethoxazole—Dizziness—Valsartan—type 2 diabetes mellitus	4.14e-05	0.000427	CcSEcCtD
Sulfamethoxazole—Anorexia—Ramipril—type 2 diabetes mellitus	4.14e-05	0.000427	CcSEcCtD
Sulfamethoxazole—Dizziness—Orlistat—type 2 diabetes mellitus	4.09e-05	0.000422	CcSEcCtD
Sulfamethoxazole—Asthenia—Metformin—type 2 diabetes mellitus	4.09e-05	0.000422	CcSEcCtD
Sulfamethoxazole—Sulfanilamide—CYP3A4—type 2 diabetes mellitus	4.07e-05	0.0201	CrCbGaD
Sulfamethoxazole—Nausea—Gliclazide—type 2 diabetes mellitus	4.05e-05	0.000418	CcSEcCtD
Sulfamethoxazole—Pruritus—Metformin—type 2 diabetes mellitus	4.04e-05	0.000416	CcSEcCtD
Sulfamethoxazole—Urticaria—Losartan—type 2 diabetes mellitus	4.02e-05	0.000415	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Losartan—type 2 diabetes mellitus	4e-05	0.000413	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Losartan—type 2 diabetes mellitus	4e-05	0.000413	CcSEcCtD
Sulfamethoxazole—Vomiting—Valsartan—type 2 diabetes mellitus	3.98e-05	0.000411	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	3.97e-05	0.000409	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	3.96e-05	0.000408	CcSEcCtD
Sulfamethoxazole—Rash—Valsartan—type 2 diabetes mellitus	3.95e-05	0.000407	CcSEcCtD
Sulfamethoxazole—Dermatitis—Valsartan—type 2 diabetes mellitus	3.95e-05	0.000407	CcSEcCtD
Sulfamethoxazole—Vomiting—Orlistat—type 2 diabetes mellitus	3.93e-05	0.000406	CcSEcCtD
Sulfamethoxazole—Insomnia—Ramipril—type 2 diabetes mellitus	3.93e-05	0.000405	CcSEcCtD
Sulfamethoxazole—Headache—Valsartan—type 2 diabetes mellitus	3.92e-05	0.000405	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Metformin—type 2 diabetes mellitus	3.9e-05	0.000402	CcSEcCtD
Sulfamethoxazole—Rash—Orlistat—type 2 diabetes mellitus	3.9e-05	0.000402	CcSEcCtD
Sulfamethoxazole—Dermatitis—Orlistat—type 2 diabetes mellitus	3.9e-05	0.000402	CcSEcCtD
Sulfamethoxazole—Headache—Orlistat—type 2 diabetes mellitus	3.88e-05	0.0004	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Ramipril—type 2 diabetes mellitus	3.87e-05	0.000399	CcSEcCtD
Sulfamethoxazole—Asthenia—Irbesartan—type 2 diabetes mellitus	3.86e-05	0.000398	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Ramipril—type 2 diabetes mellitus	3.82e-05	0.000394	CcSEcCtD
Sulfamethoxazole—Pruritus—Irbesartan—type 2 diabetes mellitus	3.81e-05	0.000393	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Ramipril—type 2 diabetes mellitus	3.78e-05	0.000389	CcSEcCtD
Sulfamethoxazole—Dizziness—Metformin—type 2 diabetes mellitus	3.77e-05	0.000389	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	3.75e-05	0.000387	CcSEcCtD
Sulfamethoxazole—Fatigue—Ramipril—type 2 diabetes mellitus	3.74e-05	0.000386	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Losartan—type 2 diabetes mellitus	3.73e-05	0.000385	CcSEcCtD
Sulfamethoxazole—Nausea—Valsartan—type 2 diabetes mellitus	3.72e-05	0.000384	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Irbesartan—type 2 diabetes mellitus	3.68e-05	0.00038	CcSEcCtD
Sulfamethoxazole—Nausea—Orlistat—type 2 diabetes mellitus	3.68e-05	0.000379	CcSEcCtD
Sulfamethoxazole—Asthenia—Losartan—type 2 diabetes mellitus	3.63e-05	0.000375	CcSEcCtD
Sulfamethoxazole—Dapsone—CYP3A4—type 2 diabetes mellitus	3.63e-05	0.0179	CrCbGaD
Sulfamethoxazole—Vomiting—Metformin—type 2 diabetes mellitus	3.63e-05	0.000374	CcSEcCtD
Sulfamethoxazole—Rash—Metformin—type 2 diabetes mellitus	3.6e-05	0.000371	CcSEcCtD
Sulfamethoxazole—Dermatitis—Metformin—type 2 diabetes mellitus	3.59e-05	0.00037	CcSEcCtD
Sulfamethoxazole—Pruritus—Losartan—type 2 diabetes mellitus	3.58e-05	0.00037	CcSEcCtD
Sulfamethoxazole—Headache—Metformin—type 2 diabetes mellitus	3.57e-05	0.000368	CcSEcCtD
Sulfamethoxazole—Dizziness—Irbesartan—type 2 diabetes mellitus	3.56e-05	0.000367	CcSEcCtD
Sulfamethoxazole—Dapsone—PTGS2—type 2 diabetes mellitus	3.56e-05	0.0176	CrCbGaD
Sulfamethoxazole—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	3.55e-05	0.000366	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Losartan—type 2 diabetes mellitus	3.47e-05	0.000357	CcSEcCtD
Sulfamethoxazole—Urticaria—Ramipril—type 2 diabetes mellitus	3.45e-05	0.000356	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Ramipril—type 2 diabetes mellitus	3.43e-05	0.000354	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Ramipril—type 2 diabetes mellitus	3.43e-05	0.000354	CcSEcCtD
Sulfamethoxazole—Vomiting—Irbesartan—type 2 diabetes mellitus	3.42e-05	0.000353	CcSEcCtD
Sulfamethoxazole—Rash—Irbesartan—type 2 diabetes mellitus	3.39e-05	0.00035	CcSEcCtD
Sulfamethoxazole—Dermatitis—Irbesartan—type 2 diabetes mellitus	3.39e-05	0.00035	CcSEcCtD
Sulfamethoxazole—Nausea—Metformin—type 2 diabetes mellitus	3.39e-05	0.000349	CcSEcCtD
Sulfamethoxazole—Headache—Irbesartan—type 2 diabetes mellitus	3.37e-05	0.000348	CcSEcCtD
Sulfamethoxazole—Dizziness—Losartan—type 2 diabetes mellitus	3.35e-05	0.000345	CcSEcCtD
Sulfamethoxazole—Vomiting—Losartan—type 2 diabetes mellitus	3.22e-05	0.000332	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Ramipril—type 2 diabetes mellitus	3.2e-05	0.00033	CcSEcCtD
Sulfamethoxazole—Nausea—Irbesartan—type 2 diabetes mellitus	3.2e-05	0.00033	CcSEcCtD
Sulfamethoxazole—Rash—Losartan—type 2 diabetes mellitus	3.19e-05	0.000329	CcSEcCtD
Sulfamethoxazole—Dermatitis—Losartan—type 2 diabetes mellitus	3.19e-05	0.000329	CcSEcCtD
Sulfamethoxazole—Headache—Losartan—type 2 diabetes mellitus	3.17e-05	0.000327	CcSEcCtD
Sulfamethoxazole—Asthenia—Ramipril—type 2 diabetes mellitus	3.12e-05	0.000321	CcSEcCtD
Sulfamethoxazole—Pruritus—Ramipril—type 2 diabetes mellitus	3.07e-05	0.000317	CcSEcCtD
Sulfamethoxazole—Nausea—Losartan—type 2 diabetes mellitus	3.01e-05	0.00031	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Ramipril—type 2 diabetes mellitus	2.97e-05	0.000306	CcSEcCtD
Sulfamethoxazole—Dizziness—Ramipril—type 2 diabetes mellitus	2.87e-05	0.000296	CcSEcCtD
Sulfamethoxazole—Vomiting—Ramipril—type 2 diabetes mellitus	2.76e-05	0.000285	CcSEcCtD
Sulfamethoxazole—Rash—Ramipril—type 2 diabetes mellitus	2.74e-05	0.000282	CcSEcCtD
Sulfamethoxazole—Dermatitis—Ramipril—type 2 diabetes mellitus	2.74e-05	0.000282	CcSEcCtD
Sulfamethoxazole—Headache—Ramipril—type 2 diabetes mellitus	2.72e-05	0.000281	CcSEcCtD
Sulfamethoxazole—Nausea—Ramipril—type 2 diabetes mellitus	2.58e-05	0.000266	CcSEcCtD
Sulfamethoxazole—CYP2C8—Metabolism—GCK—type 2 diabetes mellitus	3.95e-06	8.25e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	3.93e-06	8.21e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—LIPC—type 2 diabetes mellitus	3.93e-06	8.2e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GCK—type 2 diabetes mellitus	3.93e-06	8.2e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—HBA1—type 2 diabetes mellitus	3.93e-06	8.2e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CYP11A1—type 2 diabetes mellitus	3.93e-06	8.2e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—AGT—type 2 diabetes mellitus	3.92e-06	8.18e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—APOB—type 2 diabetes mellitus	3.91e-06	8.16e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CYP11A1—type 2 diabetes mellitus	3.9e-06	8.15e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	3.89e-06	8.13e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—SERPINE1—type 2 diabetes mellitus	3.89e-06	8.12e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ALDOB—type 2 diabetes mellitus	3.88e-06	8.1e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—SLC9A1—type 2 diabetes mellitus	3.86e-06	8.05e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—CALM1—type 2 diabetes mellitus	3.85e-06	8.04e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—APOE—type 2 diabetes mellitus	3.84e-06	8.01e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—SLC9A1—type 2 diabetes mellitus	3.83e-06	8.01e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CETP—type 2 diabetes mellitus	3.81e-06	7.96e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—GSTM1—type 2 diabetes mellitus	3.8e-06	7.94e-05	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—AKT1—type 2 diabetes mellitus	3.8e-06	7.93e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—APOA1—type 2 diabetes mellitus	3.79e-06	7.92e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CETP—type 2 diabetes mellitus	3.79e-06	7.91e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	3.79e-06	7.91e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	3.79e-06	7.91e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	3.77e-06	7.87e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—LPL—type 2 diabetes mellitus	3.73e-06	7.79e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—NOS3—type 2 diabetes mellitus	3.71e-06	7.75e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—PIK3R1—type 2 diabetes mellitus	3.71e-06	7.75e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	3.69e-06	7.71e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	3.69e-06	7.71e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—ADCY5—type 2 diabetes mellitus	3.65e-06	7.63e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	3.65e-06	7.62e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—GPX1—type 2 diabetes mellitus	3.64e-06	7.6e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GLP1R—type 2 diabetes mellitus	3.61e-06	7.53e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	3.55e-06	7.42e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—CD36—type 2 diabetes mellitus	3.55e-06	7.4e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—SREBF1—type 2 diabetes mellitus	3.54e-06	7.4e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—SNAP25—type 2 diabetes mellitus	3.54e-06	7.4e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PSMD6—type 2 diabetes mellitus	3.54e-06	7.4e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PSMD6—type 2 diabetes mellitus	3.52e-06	7.36e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—SREBF1—type 2 diabetes mellitus	3.52e-06	7.36e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—SNAP25—type 2 diabetes mellitus	3.52e-06	7.36e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	3.52e-06	7.35e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	3.52e-06	7.35e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	3.52e-06	7.35e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PPP2CA—type 2 diabetes mellitus	3.5e-06	7.31e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CTGF—type 2 diabetes mellitus	3.48e-06	7.26e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CTGF—type 2 diabetes mellitus	3.46e-06	7.22e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—HMGCR—type 2 diabetes mellitus	3.45e-06	7.2e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—HMGCR—type 2 diabetes mellitus	3.43e-06	7.16e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	3.4e-06	7.1e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	3.38e-06	7.06e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	3.38e-06	7.05e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	3.38e-06	7.05e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ADRA2A—type 2 diabetes mellitus	3.37e-06	7.04e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—SLC2A2—type 2 diabetes mellitus	3.37e-06	7.03e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—MTHFR—type 2 diabetes mellitus	3.36e-06	7.02e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—ADRA2A—type 2 diabetes mellitus	3.35e-06	7e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PPARG—type 2 diabetes mellitus	3.34e-06	6.98e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—AKT1—type 2 diabetes mellitus	3.31e-06	6.91e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	3.3e-06	6.89e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	3.3e-06	6.89e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PPARA—type 2 diabetes mellitus	3.3e-06	6.88e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—INS—type 2 diabetes mellitus	3.28e-06	6.85e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	3.25e-06	6.79e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	3.25e-06	6.79e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CYP2E1—type 2 diabetes mellitus	3.24e-06	6.77e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	3.24e-06	6.76e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CYP2E1—type 2 diabetes mellitus	3.22e-06	6.73e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	3.22e-06	6.72e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	3.22e-06	6.71e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	3.22e-06	6.71e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	3.22e-06	6.71e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CYP1A2—type 2 diabetes mellitus	3.2e-06	6.69e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—SLC2A1—type 2 diabetes mellitus	3.2e-06	6.69e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	3.2e-06	6.67e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	3.19e-06	6.67e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—AGT—type 2 diabetes mellitus	3.19e-06	6.67e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CYP1A2—type 2 diabetes mellitus	3.19e-06	6.65e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—SLC2A1—type 2 diabetes mellitus	3.19e-06	6.65e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—CALM1—type 2 diabetes mellitus	3.14e-06	6.56e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	3.14e-06	6.55e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	3.14e-06	6.55e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	3.14e-06	6.55e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	3.14e-06	6.55e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—APOE—type 2 diabetes mellitus	3.13e-06	6.53e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CYP3A4—type 2 diabetes mellitus	3.13e-06	6.53e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.11e-06	6.49e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CYP3A4—type 2 diabetes mellitus	3.11e-06	6.49e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	3.1e-06	6.48e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—APOA1—type 2 diabetes mellitus	3.09e-06	6.46e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.09e-06	6.46e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GCG—type 2 diabetes mellitus	3.07e-06	6.42e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—SLC2A4—type 2 diabetes mellitus	3.07e-06	6.42e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GCG—type 2 diabetes mellitus	3.06e-06	6.38e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—SLC2A4—type 2 diabetes mellitus	3.06e-06	6.38e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—ALB—type 2 diabetes mellitus	3.01e-06	6.28e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	2.95e-06	6.16e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	2.89e-06	6.04e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	2.88e-06	6.02e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	2.88e-06	6.02e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	2.88e-06	6.02e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PIK3R1—type 2 diabetes mellitus	2.88e-06	6e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—NOS3—type 2 diabetes mellitus	2.88e-06	6e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	2.83e-06	5.91e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	2.81e-06	5.86e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	2.77e-06	5.78e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	2.76e-06	5.77e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—SRC—type 2 diabetes mellitus	2.75e-06	5.73e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	2.75e-06	5.73e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PPARG—type 2 diabetes mellitus	2.73e-06	5.69e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—VEGFA—type 2 diabetes mellitus	2.68e-06	5.59e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—INS—type 2 diabetes mellitus	2.67e-06	5.58e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	2.67e-06	5.57e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	2.67e-06	5.57e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	2.67e-06	5.57e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	2.67e-06	5.57e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.65e-06	5.53e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GNB3—type 2 diabetes mellitus	2.65e-06	5.53e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	2.64e-06	5.51e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—HMOX1—type 2 diabetes mellitus	2.64e-06	5.5e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.63e-06	5.5e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GNB3—type 2 diabetes mellitus	2.63e-06	5.5e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PTGS2—type 2 diabetes mellitus	2.63e-06	5.49e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—HMOX1—type 2 diabetes mellitus	2.62e-06	5.47e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	2.61e-06	5.45e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	2.61e-06	5.45e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CAT—type 2 diabetes mellitus	2.6e-06	5.43e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CAT—type 2 diabetes mellitus	2.59e-06	5.4e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	2.56e-06	5.34e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	2.54e-06	5.31e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.53e-06	5.28e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—APOB—type 2 diabetes mellitus	2.53e-06	5.27e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—APOB—type 2 diabetes mellitus	2.51e-06	5.24e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	2.5e-06	5.22e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	2.5e-06	5.22e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	2.46e-06	5.13e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—TGFB1—type 2 diabetes mellitus	2.46e-06	5.13e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—ALB—type 2 diabetes mellitus	2.45e-06	5.12e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GSTM1—type 2 diabetes mellitus	2.44e-06	5.1e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	2.41e-06	5.03e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—LPL—type 2 diabetes mellitus	2.4e-06	5.01e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	2.38e-06	4.97e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	2.36e-06	4.93e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	2.35e-06	4.91e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—ADCY5—type 2 diabetes mellitus	2.35e-06	4.9e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—NOS3—type 2 diabetes mellitus	2.34e-06	4.89e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.34e-06	4.89e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GPX1—type 2 diabetes mellitus	2.34e-06	4.88e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	2.29e-06	4.78e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CD36—type 2 diabetes mellitus	2.28e-06	4.76e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	2.26e-06	4.72e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PPP2CA—type 2 diabetes mellitus	2.25e-06	4.7e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	2.22e-06	4.64e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	2.18e-06	4.54e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	2.18e-06	4.54e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	2.17e-06	4.53e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—MTHFR—type 2 diabetes mellitus	2.16e-06	4.51e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.16e-06	4.5e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	2.16e-06	4.5e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	2.15e-06	4.48e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PTGS2—type 2 diabetes mellitus	2.14e-06	4.48e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	2.13e-06	4.46e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	2.13e-06	4.45e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	2.12e-06	4.43e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	2.12e-06	4.43e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	2.12e-06	4.43e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PPARA—type 2 diabetes mellitus	2.12e-06	4.42e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	2.12e-06	4.42e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	2.11e-06	4.4e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	2.07e-06	4.32e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	2.06e-06	4.31e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	2.06e-06	4.29e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—AGT—type 2 diabetes mellitus	2.05e-06	4.28e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	2.05e-06	4.27e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	2.03e-06	4.23e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	2.02e-06	4.22e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CALM1—type 2 diabetes mellitus	2.02e-06	4.21e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—APOE—type 2 diabetes mellitus	2.01e-06	4.2e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	2e-06	4.17e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	2e-06	4.17e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—APOA1—type 2 diabetes mellitus	1.99e-06	4.15e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	1.96e-06	4.1e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	1.92e-06	4.01e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	1.91e-06	4e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	1.9e-06	3.97e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	1.9e-06	3.97e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	1.9e-06	3.97e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	1.87e-06	3.9e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	1.86e-06	3.89e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	1.85e-06	3.86e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	1.84e-06	3.84e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	1.81e-06	3.78e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	1.77e-06	3.69e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	1.76e-06	3.68e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PPARG—type 2 diabetes mellitus	1.75e-06	3.65e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	1.74e-06	3.63e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	1.73e-06	3.62e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	1.73e-06	3.6e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	1.72e-06	3.59e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	1.72e-06	3.59e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—INS—type 2 diabetes mellitus	1.72e-06	3.58e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—AKT1—type 2 diabetes mellitus	1.71e-06	3.56e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	1.68e-06	3.5e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	1.65e-06	3.45e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	1.65e-06	3.44e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	1.65e-06	3.44e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	1.64e-06	3.43e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	1.63e-06	3.39e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	1.58e-06	3.3e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	1.51e-06	3.16e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	1.51e-06	3.16e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PIK3R1—type 2 diabetes mellitus	1.51e-06	3.14e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—NOS3—type 2 diabetes mellitus	1.51e-06	3.14e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	1.43e-06	2.99e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.42e-06	2.97e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.42e-06	2.97e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.41e-06	2.95e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	1.41e-06	2.93e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.4e-06	2.91e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	1.38e-06	2.89e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PTGS2—type 2 diabetes mellitus	1.38e-06	2.87e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.36e-06	2.83e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—AKT1—type 2 diabetes mellitus	1.32e-06	2.76e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.32e-06	2.75e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.29e-06	2.7e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	1.29e-06	2.69e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.27e-06	2.65e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.26e-06	2.64e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	1.23e-06	2.57e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	1.23e-06	2.57e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.23e-06	2.57e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.21e-06	2.54e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.17e-06	2.43e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.14e-06	2.39e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	1.13e-06	2.35e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.11e-06	2.31e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.09e-06	2.27e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.08e-06	2.26e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—AKT1—type 2 diabetes mellitus	1.08e-06	2.25e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.07e-06	2.24e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	9.45e-07	1.97e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	9.27e-07	1.93e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	8.5e-07	1.77e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	8.13e-07	1.7e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	8.13e-07	1.7e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	7.43e-07	1.55e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	6.96e-07	1.45e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—AKT1—type 2 diabetes mellitus	6.92e-07	1.44e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	5.66e-07	1.18e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	3.74e-07	7.8e-06	CbGpPWpGaD
